RELIEF THERAPEUTICS HLDG AG (RLFTY, $3.25) was a top loser over the last three months, falling to $3.25 per share. A.I.dvisor analyzed 848 stocks in the Biotechnology Industry for the 3-month period ending April 15, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.